Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells

Monica Marra, Daniele Santini, Giuseppina Meo, Bruno Vincenzi, Silvia Zappavigna, Alfonso Baldi, Maciej Rosolowski, Giuseppe Tonini, Markus Loeffler, Ruth Lupu, Santolo Rosario Addeo, Alberto Abbruzzese, Alfredo Budillon, Michele Caraglia

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences